Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group
Colorectal Disease · 2023
DOI: 10.1111/codi.16742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2023. Verfasst von Mélanie Calmels und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, DMU Digest, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris-Cité, Clichy, Fran…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Digestive System Surgical Procedures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Aim
A complete or subcomplete tumour response (CTR) is observed in 10%–25% of patients with mid/low rectal cancer after neoadjuvant chemoradiotherapy (CRT). The aim of our study was to report a multicentric French experience in local excision (LE) after CRT.
Method
All patients who underwent LE for mid/low rectal cancer with suspected CTR after CRT, from 2006 to 2019 in seven GRECCAR centres were included. LE was considered adequate if the specimen showed a ypT0/Tis/T1R0 tumour, otherwise, a completion total mesorectal excision (TME) was discussed. Morbi‐mortality, functional results and oncological outcomes were studied.
Results
A total of 257 patients were included. LE specimens showed 36% ypT0, 4% ypTis and 19% ypT1. Thus, 108 patients (42%) had theoretical indication of completion TME, which was performed in only 42 patients. Overall, 30‐day morbidity after LE was 11%, including 2% Clavien–Dindo grade III or IV complications. After completion TME, 47% described major low anterior resection syndrome versus 5% after LE alone ( p < 0.001). After a mean follow‐up of 4 years (range 2–6 years), the recurrence rate was 11% after LE, 32% after completion TME and 20% in patients for whom completion TME was indicated but not performed ( p = 0.021).
Conclusion
TME remains the gold standard for mid/low rectal cancer after CRT. LE in selected patients is safe for operative and functional, but also oncological, results. However, completion TME was indicated in 42% of patients after LE, highlighting the difficulty of the preoperative diagnosis of CTR after CRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, DMU Digest, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris-Cité, Clichy, France.
- Surgical Oncology Department, Institut Paoli Calmettes, Marseille, France.
- Surgery Department, Saint Antoine University Hospital, Paris, France.
- Surgery Department, Rouen University Hospital, Rouen, France.
- Digestive Surgery Department, Bicêtre University Hospital, Le Kremlin-Bicêtre, France.
- Surgery Department, Timone University Hospital, Marseille, France.
ORCID-Profile: Diane Mège
Zitieren
APA
Calmels, M., Labiad, C., Lelong, B., Lefevre, J. H., Tuech, J. J., Benoist, S., Mège, D., Denost, Q., & Panis, Y. (2023). Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group. Colorectal Disease. https://doi.org/10.1111/codi.16742
Vancouver
Calmels M, Labiad C, Lelong B, Lefevre JH, Tuech JJ, Benoist S, et al. Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group. Colorectal Disease. 2023. doi:10.1111/codi.16742
BibTeX
@article{Calmels2023,
author = {Calmels, Mélanie and Labiad, Camélia and Lelong, Bernard and Lefevre, Jérémie H and Tuech, Jean-Jacques and Benoist, Stéphane and Mège, Diane and Denost, Quentin and Panis, Yves},
title = {Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group},
journal = {Colorectal Disease},
year = {2023},
doi = {10.1111/codi.16742}
}
EUVIMED